Jelena Vasilevska | Aging Mechanisms | Innovative Research Award

Published on by Cell Biologist

Innovative Research Award

Jelena Vasilevska
Center for Genetics and Life Science, Sirius University of Science and Technology, Russia

Jelena Vasilevska
Affiliation Center for Genetics and Life Science, Sirius University of Science and Technology
Country Russia
Scopus ID 55319310900
Documents 13
Citations 330
h-index 8
Subject Area Aging Mechanisms
Event World Cell Biologist Awards
ORCID 0009-0001-2192-8954

Jelena Vasilevska is a researcher affiliated with the Center for Genetics and Life Science at Sirius University of Science and Technology in Russia, whose stated subject area is the study of aging mechanisms. Bibliographic information supplied for this academic recognition profile records 13 documents, 330 citations, and an h-index of 8 in Scopus. [1] Her researcher identity is additionally represented through an ORCID record, providing a persistent identifier for scholarly activities and publications. [2]

Abstract

Jelena Vasilevska is affiliated with the Center for Genetics and Life Science, Sirius University of Science and Technology, Russia. Her identified research subject is aging mechanisms, a multidisciplinary area concerned with the biological processes that influence cellular and organismal aging. The supplied bibliometric profile reports 13 Scopus-indexed documents, 330 citations, and an h-index of 8. [1] These indicators provide quantitative context for her documented scholarly output and citation visibility. The researcher also maintains an ORCID identifier, supporting persistent attribution of scholarly contributions. [2]

Keywords

Aging mechanisms; Cell biology; Biogerontology; Cellular aging; Molecular mechanisms of aging; Research impact; Scientific publications; Innovative research

Introduction

Aging is a complex biological phenomenon involving interconnected molecular, cellular, physiological, and environmental processes. Contemporary research into aging mechanisms examines changes in genomic stability, cellular communication, mitochondrial function, proteostasis, nutrient sensing, cellular senescence, stem-cell function, and other processes that contribute to age-associated changes. [3]

The academic profile described here is based on the supplied researcher information and bibliographic identifiers. Scopus provides author-level bibliographic and citation information, while ORCID supplies a persistent researcher identifier designed to distinguish scholars and connect their research outputs. [1] [2]

Research Profile

Jelena Vasilevska as a researcher at the Center for Genetics and Life Science, Sirius University of Science and Technology. Her principal subject area is recorded as aging mechanisms. The bibliometric indicators supplied for this profile are 13 documents, 330 citations, and an h-index of 8. [1]

Research Contributions

The principal research theme associated with this profile is the study of aging mechanisms. Research in this area commonly seeks to clarify the biological pathways that regulate aging and the cellular changes associated with increasing age. A widely used framework for understanding this field describes interconnected hallmarks of aging, including genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem-cell exhaustion, and altered intercellular communication. [3] [4]

Publications

The supplied Scopus profile records 13 documents associated with the researcher identifier 55319310900. [1] Individual publication titles, journal information, publication years, co-authors, and DOI metadata are not included in the supplied input and are therefore not reproduced here as independently verified publication-level records. [5] [2]

Research Impact

The supplied bibliometric profile reports 330 citations across 13 documents, with an h-index of 8. [1] These values indicate that the documented publication set has received citation attention within the indexed scholarly literature. The h-index provides a combined measure of publication productivity and citation impact, although it does not capture every dimension of research influence.[4]

Award Suitability

The Innovative Research Award recognition is associated with the World Cell Biologist Awards. Based on the information supplied for this profile, the award context corresponds to a researcher whose identified scientific subject is aging mechanisms and whose bibliometric record includes 13 documents, 330 citations, and an h-index of 8. [1]

Conclusion

Jelena Vasilevska is profiled as a researcher affiliated with the Center for Genetics and Life Science, Sirius University of Science and Technology, Russia, with a stated research focus on aging mechanisms. The supplied Scopus metrics comprise 13 documents, 330 citations, and an h-index of 8. [1] Her ORCID identifier provides a persistent mechanism for scholarly identification and attribution. [2]

References

    1. Elsevier. (n.d.). Scopus author details: Jelena Vasilevska, Author ID 55319310900. Scopus.
      https://www.scopus.com/authid/detail.uri?authorId=55319310900
    1. NA Dudko, J Vasilevska & et al. (2026). Non-Human Primates as a Comprehensive Model for Studying Epigenetic Markers of Aging.
      https://www.mdpi.com/2073-4425/17/8/905
    2. EV Simoroz, J Vasilevska, & et al. (2025). Unconventional animal models to study the role of telomeres in aging and longevity.
      https://pmc.ncbi.nlm.nih.gov/articles/PMC12280224/
    3. B Sundaram, K Behnke, J Vasilevska, & et al. (2019). iRhom2 inhibits bile duct obstruction–induced liver fibrosis.
      https://www.science.org/doi/abs/10.1126/scisignal.aax1194
    4. A Heinen, R Nederlof, J Vasilevska, & et al. (2019). IGF1 treatment improves cardiac remodeling after infarction by targeting myeloid cells
      https://www.cell.com/molecular-therapy-family/molecular-therapy/fulltext/S1525-0016(18)30527-6

Lichun Zhao | Cellular Senescence Aging | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Lichun Zhao | Cellular Senescence Aging | Best Researcher Award

Prof. Dr. Lichun Zhao | Guizhou University of Traditional Chinese Medicine | China

Dr. Lichun Zhao, Ph.D., is a distinguished researcher from Changchun, Jilin, China, currently a postdoctoral fellow at Hong Kong Baptist University and a leading academic at Guizhou University of Chinese Medicine. He serves as Director of both the Research Department and the Center for Trace Elements and Health Development. As the first National Youth Qihuang Scholar and winner of numerous prestigious awards, including the Guangxi Youth Science and Technology Award, Dr. Zhao has significantly advanced research in traditional Chinese medicine, trace elements, and mineral pharmacology. He holds editorial and leadership positions in several national academic and professional associations. With more than 200 publications. His work bridges science, technology, and healthcare innovation. Dr. Zhao remains a powerful force in scientific research and a mentor shaping the future of integrative medical sciences.

Publication Profile: 

Scopus

Education:

Dr. Lichun Zhao earned his Ph.D. from a top Chinese institution in a discipline closely linked to pharmaceutical sciences and traditional Chinese medicine (TCM). Building on his doctoral training, he advanced into postdoctoral research at Hong Kong Baptist University, a recognized hub for integrative medicine and health sciences. His academic foundation combines in-depth knowledge of biomedicine, trace elements, mineral nutrition, and traditional medicinal systems. This unique educational blend enabled him to pioneer multi-disciplinary research across TCM, pharmacology, and materials science. Dr. Zhao’s education journey reflects not only academic rigor but also his drive to merge traditional practices with modern science. His continuous learning through international collaborations, advanced certifications, and national talent programs demonstrates a lifelong commitment to scientific excellence and translational research. His education has played a pivotal role in forming his holistic, innovation-driven research vision that integrates ancient wisdom with contemporary health science.

Experience:

Dr. Zhao holds a multitude of roles showcasing his vast expertise. Currently, he is a postdoctoral fellow at Hong Kong Baptist University and a doctoral supervisor and director at Guizhou University of Chinese Medicine. He also serves as Director of Guizhou and Guangxi Key Laboratories focused on endangered medicinal materials. Additionally, he is the Executive Editor-in-Chief of Trace Elements and Health Research. Nationally recognized as a Qihuang Scholar, National Youth Post Expert, and leader in several elite Chinese talent development programs, he serves as an evaluator for China’s most prestigious science awards and grants. In his academic and professional trajectory, Dr. Zhao has hosted more than 30 major national and international research projects and contributed significantly to public health through innovative product development and clinical applications. His combined roles as researcher, leader, editor, mentor, and evaluator underscore his all-round impact in academic, industrial, and clinical ecosystems.

Research Focus:

Dr. Zhao’s research focuses on the biological roles and therapeutic potential of trace elements—notably Cu, Fe, Zn, Se, Rb, Cr, Si, and V—in relation to human health and chronic diseases, especially Alzheimer’s disease, cancer, ulcerative colitis, and chronic inflammatory conditions. He bridges Traditional Chinese Medicine (TCM) with modern bioscience, exploring minerals’ pharmacological effects, ferroptosis mechanisms, bacteriostatic mineral activity, and the integration of TCM with AI and big data. His innovative studies in MOF-polymer microreactors and rubidium salts demonstrate an advanced understanding of interfacial chemistry and drug delivery systems. He has developed Class 1.1 innovative Chinese medicine and contributed clinically approved products, highlighting his translational impact. His work also explores mitochondrial fission, apoptosis, and bioelement interactions at molecular and cellular levels. Dr. Zhao’s research philosophy is rooted in cross-disciplinary integration, with the goal of modernizing TCM and delivering tangible health benefits.

Publications Top Notes:

  1. The close relationship between trace elements (Cu, Fe, Zn, Se, Rb, Si, Cr, and V) and Alzheimer’s disease: Research progress and insights

  2. Bacteriostatic activity and mechanism of minerals containing rubidium – Science of Traditional Chinese Medicine

  3. Traditional Chinese medicine in chronic rhinosinusitis: Mechanisms and postoperative recovery – Phytomedicine

  4. Rosmarinic acid promotes mitochondrial fission and induces ferroptosis in triple-negative breast cancer cells – Naunyn Schmiedeberg’s Archives of Pharmacology

  5. Interfacial Stabilization through MOF-Polymer Core-Shell Design: Ultraefficient, Stable and Recyclable Enzymatic Microreactors – ACS Applied Materials & Interfaces

  6. Rubidium salt can effectively relieve the symptoms of DSS-induced ulcerative colitis – Biomedicine & Pharmacotherapy

Conclusion:

Dr. Lichun Zhao stands out as a multi-dimensional, high-impact researcher, blending scientific excellence, clinical innovation, technological advancement, and academic leadership. His contributions span traditional medicine, mineral pharmacology, chronic disease research, biotechnology, and national science development strategies. He embodies the vision of a modern, globally oriented researcher who successfully integrates traditional wisdom with contemporary science.

Jerome Robin | Cellular Senescence Aging | Best Researcher Award

Published on by Cell Biologist

Assoc. Prof. Dr. Jerome Robin | Cellular Senescence Aging | Best Researcher Award

Assoc. Prof. Dr. Jerome Robin , Aix Marseille Univ. / Inserm , France

Jérôme D. Robin, PhD, is an experienced researcher and Innovation Strategy Lead at ID Solutions Oncology. With expertise in cell and molecular biology, he is committed to advancing oncology diagnostics through digital PCR and companion diagnostics. He has held numerous prestigious positions, including CRCN (Tenured, INSERM) and Postdoctoral Fellow roles at renowned institutes such as UTSW and AMU/INSERM. Jérôme has demonstrated leadership in academia and industry, with contributions to the understanding of telomere biology, aging, and muscular dystrophies. He has a strong publication record, including high-impact research in telomere dynamics, aging, and disease modeling, and has been awarded multiple research grants throughout his career.

Publication Profile: 

Scopus

Strengths for the Award:

  1. Outstanding Academic Background and Expertise: Dr. Robin holds a PhD in Cell & Molecular Biology with a focus on Facio-Scapulo-Humeral Dystrophy (FSHD), and his educational trajectory, including a Master’s in Aging Biology, is highly distinguished. The advanced understanding he has developed of telomere dynamics, epigenetics, and the molecular mechanisms underlying muscle diseases is an essential strength for this award.

  2. Extensive Research Contributions: Dr. Robin has made significant contributions to the fields of aging, cancer biology, and muscular dystrophies. He has co-authored over 30 peer-reviewed publications, several of which are in high-impact journals such as Aging Cell, Nature Communications, and Sci Rep. His work on telomeres and their role in both aging and disease, especially FSHD, is pivotal and offers novel insights into therapeutic potential.

  3. Innovative and Diverse Research Areas: Dr. Robin’s research spans multiple cutting-edge areas, including:

    • Telomere biology and its implications for aging and diseases (e.g., FSHD and cancer).
    • Development of advanced diagnostic tools using droplet digital PCR and nanopore technology for precise biomarkers.
    • Use of iPSCs for modeling diseases and uncovering new therapeutic targets.
    • Epigenetics in muscle and neural diseases. His work not only explores the basic mechanisms but also translates these findings into clinical applications, such as companion diagnostics and personalized treatments.

  4. Leadership and Impact: In his current role as Oncology Innovation Strategy Lead, Dr. Robin has successfully led the creation and development of diagnostic products. His ability to integrate research into impactful product development is commendable and speaks to his interdisciplinary expertise. Additionally, his leadership in research groups, where he has supervised multiple postdoctoral fellows and PhD students, shows his ability to foster the next generation of scientists.

  5. International Recognition and Peer Review Activity: Dr. Robin’s involvement in peer review for high-profile journals (Nature Structural and Molecular Biology, Science, JAMA, etc.) and his continuous engagement with global scientific communities underscore his influence and recognition in the scientific world.

  6. Funded Research and Mentorship: Dr. Robin has received numerous prestigious grants, including from INSERM, AFM, and the FSH Society, demonstrating strong support for his research. His mentorship of students and postdoctoral fellows also enhances his profile as a leader in academia and research.

Areas for Improvement:

  1. Further Expansion of Collaborative Networks: While Dr. Robin has an impressive research portfolio, expanding his collaborations beyond the fields of molecular biology and oncology could open new avenues for integrating his findings into broader biomedical contexts, such as gene therapy or regenerative medicine.

  2. Broader Public Engagement and Science Communication: Dr. Robin’s focus has primarily been within academia and high-level publications. Engaging in more public science communication or outreach could further amplify the impact of his research, especially in rare diseases like FSHD. A wider dissemination of his findings could help educate the general public and policymakers about the importance of his research.

  3. Increased Focus on Translational Research: While Dr. Robin has shown excellent progress in translational applications, particularly in diagnostics, increasing his focus on clinical trials and therapeutic development could further elevate his research impact. Expanding collaborations with clinical researchers could accelerate the development of novel treatments.

Education:

Jérôme D. Robin holds a PhD in Cell & Molecular Biology from UPMC/UTSW (2009-2013), where he explored the implications of telomere length in Facio-Scapulo-Humeral Dystrophy (FSHD). He also completed a Master 2 in Aging Biology at Paris VI – UPMC with distinction (2008-2009), focusing on the physiology and cell biology of aging, and a Master 1 in Integrative Biology and Physiology at Paris VI – UPMC (2007-2008). His academic background equips him with strong foundations in both basic and translational biology, with a focus on telomeres, aging, and muscle pathology.

Experience:

Jérôme D. Robin currently leads Oncology Innovation Strategy at ID Solutions, focusing on developing diagnostic and companion diagnostic products using digital PCR. He has a rich research background, having worked as a Group Leader at Marseille Medical Genetics, investigating telomere epigenetics and dynamics in innovative models. He has also held postdoctoral positions at UTSW, focusing on telomerase activity and splicing in cancer. He has extensive experience supervising postdocs, PhD students, and undergraduates, while leading large-scale research initiatives in genetics and disease modeling. His expertise bridges academia and industry, ensuring impactful, clinically relevant findings.

Research Focus:

Jérôme D. Robin’s research focuses on the molecular mechanisms of telomere dynamics, aging, and disease. He has contributed to understanding the role of telomeres in muscle dystrophies, particularly Facio-Scapulo-Humeral Dystrophy (FSHD), and has developed disease models using induced pluripotent stem cells (iPSCs). His work integrates genomics, epigenetics, and molecular biology to uncover new biomarkers and therapeutic strategies for age-related diseases and cancer. His focus includes studying the interaction between telomere biology and mitochondrial function, as well as the epigenetic regulation of gene expression in muscle and stem cells.

Publications Top Notes:

  • Non-canonical telomere protection role of FOXO3a of human skeletal muscle cells regulated by the TRF2-redox axis 🧬
  • In skeletal muscle and neural crest cells, SMCHD1 regulates biological pathways relevant for Bosma syndrome and FSHD phenotype 🔬
  • Facioscapulohumeral dystrophy weakened sarcomeric contractility is mimicked in iPSC-derived innervated muscle fibres 💡
  • miR-376a-3p and miR-376b-3p overexpression in Hutchinson-Gilford progeria fibroblasts inhibits cell proliferation and induces premature senescence ⏳
  • TADeus2: a web server facilitating the clinical diagnosis by pathogenicity assessment of structural variations disarranging 3D chromatin structure 🌐

Conclusion:

Dr. Jérôme D. Robin is an exemplary researcher whose work at the intersection of cell and molecular biology, aging, and muscular dystrophies has made a significant impact on both basic and applied sciences. His innovative research, leadership in the development of diagnostic tools, and contributions to understanding complex diseases like FSHD position him as a highly deserving candidate for the Best Researcher Award. With continued focus on expanding collaborations and public engagement, he has the potential to further increase his influence and contribute to transformative advancements in biomedical research.